Hints and tips:
...Smith & Nephew has held talks to buy NuVasive, a maker of medical instruments used in spinal surgery, in a deal that would be worth more than $3bn and mark the largest acquisition by the British medical...
...Smith & Nephew goes up to “overweight” at Morgan Stanley. A V-shaped recovery in kneecaps isn’t in the price, they say....
...Smith & Nephew “lowers growth outlook amid coronavirus uncertainty” and its shares are up more than 8 per cent....
...Of the large-cap health stocks, Vermeer Partners, another London-based wealth manager, favours medical device stocks Zimmer Biomet and Smith & Nephew, given that demand for elective surgery has been deferred...
...A unit of Paul Singer’s aggressive activist fund Elliott Management has pushed for UK medical device maker Smith & Nephew to shed certain parts of its business, in a move that could make the company a more...
...Smith & Nephew states that ‘multiple [UK] private hospital groups [are] aiming for late June to restart’ – this is in line with our expectations given that the 14-week NHS deal started 30 March....
...DePuy Synthes was created following Johnson & Johnson’s $21.3bn takeover of Switzerland’s Synthes in 2012. The UK’s Smith & Nephew has mulled buying smaller rival NuVasive....
...Smith & Nephew’s bought a grommet maker. ... Plague sentiment has shifted to the positive. ... Captain Corelli’s pyrrhic win .......
...Smith & Nephew has withdrawn guidance. Johnson Matthey has closed all its ex-China Clean Air factories and cut profit targets. Gemfields has suspended emerald mining in Zambia and withdrawn guidance....
...Today’s opinion FT View: The dangerous game of Sino-American tit-for-tat A substantive offer from China could head off further escalation Lex: Smith & Nephew: shoot from the hip New chief needs to make...
...Smith & Nephew, the UK medical device maker and perennial M&A target, said its chief executive Olivier Bohuon will retire at the end of next year....
...“When drafting a will, rather than naming one particular child, stating ‘all of my nephews at the date of my death’ could have avoided this.”...
...Smith & Nephew gained 1.3 per cent to £11.63 on the back of an upgrade from Goldman Sachs....
...There are three narrators: the commandant, the nephew and a member of the Sonderkommando, the Jewish units forced to help with the disposal of gas chamber victims....
...The new chief executive of Smith & Nephew brushed off suggestions that the company needed a bigger partner as he pledged to lay out a new strategy by early August for the UK-based medical device company....
...It’s Smith & Nephew, which has slipped 4 per cent after it emerged that Johnson & Johnson wants put its $28bn cash pile to work in Switzerland by acquiring a medical devices company called Synthes....
...It lost nearly $1bn in sales last year due to various product recalls and has been on the prowl since failing to consummate a big deal for British device manufacturer Smith & Nephew....
...& Nephew and others....
...J&J earlier this year made an unsuccessful bid for Smith & Nephew, the UK hip and knee replacement company that was said to be valued at nearly $11bn....
...Earlier this year the company made an unsuccessful bid for Smith & Nephew, a UK hip and knee replacement company that was said to be valued at nearly $11bn....
...Smith & Nephew, which was trading ex-dividend, lost 1.7 per cent to 658½p after Swiss peer Synthes agreed to be bought by Johnson & Johnson....
...We may also see Smith & Nephew seeking out a white knight approach from Biomet / Synthes or possibly private equity, but it is hard to see how any of these could outbid J&J....
...Smith & Nephew lost 3 per cent to 673¼p in reaction to news that Johnson & Johnson was bidding for Synthes, the Swiss orthopaedics group....
...Here we go again… Friday’s Daily Telegraph: US orthopaedics giant Biomet is set to begin informal talks with Smith & Nephew (S&N) about a potential £15bn merger…....
...Smith & Nephew lost 0.7 per cent to 691½p after the orthopaedics division of Johnson & Johnson reported slowing sales....
International Edition